(CLSD) Clearside Biomedical - Performance -26.9% in 12m
CLSD performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-64.15%
#136 in Peer-Group
Rel. Strength
18.68%
#6232 in Stock-Universe
Total Return 12m
-26.87%
#141 in Peer-Group
Total Return 5y
-48.55%
#109 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 1.58 USD |
| 52 Week Low | 0.74 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 93.11 |
| Buy/Sell Signal +-5 | 0.95 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CLSD (-26.9%) vs XLV (-6.7%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
0.9% | 131% | 354% | 62.6 | 55.3 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
2.5% | 13.5% | 82% | 19.4 | 14.7 | 1.44 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-1.93% | -14.5% | 419% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
-0.79% | 0.39% | 50.8% | 19.5 | 14.7 | 1.44 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-8.02% | 2.74% | 50.2% | 19.1 | 8.73 | 0.38 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
-3.54% | -6.89% | 49.9% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| SFZN SW Siegfried Holding |
-6.74% | -9.61% | 106% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| UCB BR UCB |
3.73% | 19% | 62.6% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: CLSD vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for CLSD
| Total Return (including Dividends) | CLSD | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 9.50% | 0.06% | 4.01% |
| 3 Months | 15.69% | -0.76% | 17.14% |
| 12 Months | -26.87% | -6.69% | 13.46% |
| 5 Years | -48.55% | 44.47% | 112.73% |
| Trend Score (consistency of price movement) | CLSD | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 51.4% | 32.3% | 90.3% |
| 3 Months | -16.3% | -15.4% | 97.5% |
| 12 Months | -84.2% | -78.9% | 46.4% |
| 5 Years | -80.6% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th75.50 | 9.43% | 5.28% |
| 3 Month | %th45.50 | 16.57% | -1.24% |
| 12 Month | %th31.00 | -21.62% | -35.55% |
| 5 Years | %th46.00 | -64.39% | -75.82% |
FAQs
Does Clearside Biomedical (CLSD) outperform the market?
No,
over the last 12 months CLSD made -26.87%, while its related Sector, the Health Care Sector SPDR (XLV) made -6.69%.
Over the last 3 months CLSD made 15.69%, while XLV made -0.76%.
Performance Comparison CLSD vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CLSD vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 8.1% | 5.5% | -12.7% | -40% |
| US NASDAQ 100 | QQQ | 8.2% | 5.3% | -14.7% | -40% |
| German DAX 40 | DAX | 7.8% | 8.3% | -24.8% | -57% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 6.9% | 5% | -17.2% | -46% |
| Hongkong Hang Seng | HSI | 7.2% | 6.7% | -34.7% | -62% |
| India NIFTY 50 | INDA | 9.5% | 10.3% | -13.2% | -24% |
| Brasil Bovespa | EWZ | 12.3% | 10.1% | -27.8% | -28% |
CLSD vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 9.5% | 7.8% | -16% | -51% |
| Consumer Discretionary | XLY | 7.2% | 6.2% | -5% | -45% |
| Consumer Staples | XLP | 10.2% | 9.6% | -11.8% | -34% |
| Energy | XLE | 5.2% | 5.4% | -5.2% | -29% |
| Financial | XLF | 9.6% | 6.9% | -15% | -52% |
| Health Care | XLV | 8% | 9.4% | -1.2% | -20% |
| Industrial | XLI | 7.7% | 5.1% | -18.6% | -50% |
| Materials | XLB | 7.4% | 5% | -13.3% | -31% |
| Real Estate | XLRE | 8.4% | 9.6% | -11.2% | -35% |
| Technology | XLK | 8.2% | 2.9% | -17.8% | -38% |
| Utilities | XLU | 8% | 6.9% | -16.7% | -47% |
| Aerospace & Defense | XAR | 7.5% | 2.7% | -32.7% | -76% |
| Biotech | XBI | 4.5% | 6.4% | -2.5% | -16% |
| Homebuilder | XHB | 5% | 0.7% | -6.1% | -26% |
| Retail | XRT | 8.2% | 6.3% | -7.9% | -33% |
CLSD vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 7.5% | 6.20% | 1.20% | -22% |
| Natural Gas | UNG | 9.8% | 16% | 13.3% | -25% |
| Gold | GLD | 8% | 9.3% | -30.6% | -65% |
| Silver | SLV | 3.8% | 3.2% | -34.7% | -49% |
| Copper | CPER | -2.2% | -5.5% | -32.3% | -50% |
CLSD vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 9% | 9.5% | -7.4% | -23% |
| iShares High Yield Corp. Bond | HYG | 8.7% | 8.4% | -9.7% | -36% |